Therapeutic Confirmatory (Phase III)

3,259 trials 1,319 recruiting

Filter these 3,259 trials by condition, country, sponsor and more.

Open in Search →

Daridorexant treatment in adolescents with enuresis. Recruiting

2025-521443-20-00 Nocturnal enuresis 2026-03-11
Low dose corticosteroids adjacent to enzyme replacement therapy or chaperon therapy in patients with cardiac manifestation of Fabry disease Recruiting

2025-521408-24-00 Fabry disease 2026-03-05
A Phase III Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients with Recurrent Glioblastoma Recruiting

2025-521785-10-00 Glioblastoma 2026-03-04
Essentiale® liquid once-daily Phase III study Recruiting

2025-521678-32-00 MASLD (Metabolic Dysfunction-Associated Steatotic Liver 2026-03-03
A Phase 3 Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Bipol… Recruiting

2025-521845-26-00 BP-I mania or mania with mixed features 2026-03-02
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder Recruiting

2025-523202-32-00 Major Depressive Disorder 2026-02-26
A Study to Evaluate Atumelnant in Adults with Congenital Adrenal Hyperplasia Recruiting

2024-519579-24-00 Classic Congenital Adrenal Hyperplasia 2026-02-26
A Phase III, randomized, controlled study of furazidin for bacterial vaginosis. Recruiting

2024-515332-80-00 Bacterial vaginosis 2026-02-23
A phase 3 efficacy and safety study of fosmanogepix for the treatment of adult patients with invasive mold infections Recruiting

2024-516216-16-00 Invasive mold infections caused by Aspergillus spp., Fu 2026-02-13
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Trepostini… Recruiting

2025-521558-40-00 Pulmonary Hypertension Associated with Interstitial Lun 2026-02-12
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRES… Recruiting

2025-522170-36-00 Diabetes Mellitus, Type 1 2026-02-03
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 2026-01-27
A clinical study of sacituzumab tirumotecan for cervical cancer (MK-2870-036) Recruiting

2025-521514-26-00 Persistent, Recurrent, or Newly Diagnosed Metastatic Ce 2026-01-26
EASE SBS 5 (Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS) Recruiting

2024-512486-14-00 Short Bowel Syndrome 2026-01-22
A Global Phase 3 Open-Label Extension Study to Assess AOC 1001 in Patients with DM1 Recruiting

2025-520766-22-00 Myotonic Dystrophy Type 1 2026-01-21
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults (BARICADE-DELAY) Recruiting

2025-521797-34-00 Diabetes Mellitus, Type 1 2026-01-20
STOP-HAE: A Phase 3 Study of ADX-324 in HAE Recruiting

2025-521352-38-00 Hereditary Angioedema 2026-01-16
A study to assess efficacy and safety of empasiprubart versus IVIg in adults with CIDP ("emvigorate") Recruiting

2024-520097-36-00 Chronic inflammatory demyelinating polyneuropathy (CIDP 2026-01-07
A study to learn how safe bimekizumab is and how well it works in adults with palmoplantar pustulosis Recruiting

2024-520337-80-00 Palmoplantar Pustulosis 2026-01-07
Randomised, Multicentre, Multinational, Double-Blind Integrated Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity … Recruiting

2025-521562-95-00 Previously Untreated Advanced (Unresectable or Metastat 2025-12-30
A study to compare Efficacy, Safety and How the Body Absorbs, Distributes, and Eliminates of Subcutaneous CT-P44 and Darzalex Faspro in Comb… Recruiting

2024-518588-36-00 Refractory or Relapsed Multiple Myeloma 2025-12-24
A clinical study of the anti-cancer effects of an investigational therapy or chemotherapy in patients with recurring uterine cancer Recruiting

2023-507525-42-00 Endometrial cancer 2025-12-23
Study to investigate lifileucel regimen plus pembrolizumab compared with pembrolizumab alone in participants with untreated, advanced melano… Recruiting

2022-503140-41-00 Melanoma 2025-12-19
A Long-Term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older with Moderate to Severe Eczema Recruiting

2023-509124-18-00 Moderate-to-Severe Atopic Dermatitis 2025-12-19